Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham V Brown

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Plos Pathogens|March 8, 2011
Expression of P. falciparum var genes involves exchange of the histone variant H2A.Z at the promoterMichaela Petter, Chin Chin Lee, Timothy J Byrne, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|January 18, 2006
Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unitKarin A Thursky, Kirsty L Buising, Narin Bak, et al.
Infection and Immunity|July 25, 2006
Transcribed var genes associated with placental malaria in Malawian womenMichael F Duffy, Aphrodite Caragounis, Rintis Noviyanti, et al.
The American Journal of Tropical Medicine and Hygiene|July 11, 2007
Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csaJames G Beeson, Francis Ndungu, Kristina E M Persson, et al.
The Journal of Infectious Diseases|May 7, 2014
Decreasing malaria prevalence and its potential consequences for immunity in pregnant womenAndrew Teo, Wina Hasang, Louise M Randall, et al.
Molecular and Biochemical Parasitology|April 25, 2006
VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparumMichael F Duffy, Alexander G Maier, Timothy J Byrne, et al.
Respiratory Medicine|September 8, 2007
A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPDAnastasia F Hutchinson, Anil K Ghimire, Michelle A Thompson, et al.
Infection and Immunity|May 2, 2007
Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1Salenna R Elliott, Timothy P Spurck, Joelle M Dodin, et al.
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Plos Pathogens|March 8, 2011
Expression of P. falciparum var genes involves exchange of the histone variant H2A.Z at the promoterMichaela Petter, Chin Chin Lee, Timothy J Byrne, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|January 18, 2006
Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unitKarin A Thursky, Kirsty L Buising, Narin Bak, et al.
Infection and Immunity|July 25, 2006
Transcribed var genes associated with placental malaria in Malawian womenMichael F Duffy, Aphrodite Caragounis, Rintis Noviyanti, et al.
The American Journal of Tropical Medicine and Hygiene|July 11, 2007
Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csaJames G Beeson, Francis Ndungu, Kristina E M Persson, et al.
The Journal of Infectious Diseases|May 7, 2014
Decreasing malaria prevalence and its potential consequences for immunity in pregnant womenAndrew Teo, Wina Hasang, Louise M Randall, et al.
Molecular and Biochemical Parasitology|April 25, 2006
VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparumMichael F Duffy, Alexander G Maier, Timothy J Byrne, et al.
Respiratory Medicine|September 8, 2007
A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPDAnastasia F Hutchinson, Anil K Ghimire, Michelle A Thompson, et al.
Infection and Immunity|May 2, 2007
Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1Salenna R Elliott, Timothy P Spurck, Joelle M Dodin, et al.
Vaccine|November 8, 2003
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean childrenBlaise Genton, Fadwa Al-Yaman, Inoni Betuela, et al.
The Journal of Infectious Diseases|March 29, 2002
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New GuineaBlaise Genton, Inoni Betuela, Ingrid Felger, et al.
Pageof 6